Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Neoplasm × ARQ 197 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9 Carcinoma, Non-Small-Cell Lung 3 Solid Tumors 2 Carcinoma, Hepatocellular 2 Solid Neoplasm 1 Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1 Fibrosis 1 Childhood Solid Neoplasm 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Adult Solid Neoplasm 1

Interventions

veliparib 1 tipifarnib 1 pazopanib 1 Mitozytrex 1 Mitomycin 1 Immunoglobulin G 1 Erlotinib Hydrochloride 1 Disulfides 1 Bevacizumab 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01749384 2017-10-12

Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Completed

Solid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡